Interleukin-6 and high mobility group box protein-1 in synovial membranes and osteochondral fragments in equine osteoarthritis

Research in Veterinary Science

Volumn 86, Issue 3, 2009, Pages 490-497

  Ley, C ^a   Ekman, S ^a   Roneus B ^b   Eloranta, M L ^c  

^a SWEDISH UNIVERSITY OF AGRICULTURAL SCIENCES   (Sweden)

^b Mälaren Hästklinik AB   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

Cytokines; Equine; HMGB 1; IL 6; Osteoarthritis; Osteochondral fragment

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 6;

ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CONTROLLED STUDY; HORSE; INFLAMMATION; NONHUMAN; OSTEOARTHRITIS; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN SECRETION; SYNOVIOCYTE; SYNOVITIS; SYNOVIUM;

AGING; ANIMALS; ARTHROSCOPY; HMGB1 PROTEIN; HORSE DISEASES; HORSES; INTERLEUKIN-6; JOINTS; OSTEOARTHRITIS; OSTEOCHONDRITIS; REFERENCE VALUES;

EQUIDAE;

EID: 64449083537     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2008.10.008     Document Type: Article

References (43)

1. Af Klint E., Grundtman C., Engström M., Catrina A.I., Makrygiannakis D., Klareskog L., Andersson U., and Ulfgren A.-K. Intraarticular glucocorticoid treatment reduces inflammation in synovial cell infiltrations more efficiently than in synovial blood vessels. Arthritis and Rheumatism 52 (2005) 3880-3889
2. Ahn J.K., Koh E.-M., Cha H.-S., Lee Y.S., Kim J., Bae E.-K., and Ahn K.-S. Role of hypoxia-inducible factor-1α in hypoxia-induced expressions of IL-8, MMP-1 and MMP-3 in rheumatoid fibroblast-like synoviocytes. Rheumatology 47 (2008) 834-839
3. Andersson U., and Erlandsson-Harris H. HMGB1 is a potent trigger of arthritis. Journal of Internal Medicine 255 (2004) 344-350
4. Andersson U., Wang H., Palmblad K., Aveberger A.-C., Bloom O., Erlandsson-Harris H., Janson A., Kokkola R., Zhang M., Yang H., and Tracey K.J. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. The Journal of Experimental Medicine 192 (2000) 565-570
5. Andersson U., Erlandsson-Harris H., Yang H., and Tracey K.J. HMGB1 as a DNA-binding cytokine. Journal of Leukocyte Biology 72 (2002) 1084-1091
6. Attur, M., Dave, M., Akamatsu, M., Nakagawa, N., Miki, J., Yang, H., Katoh, M., Wisniewski, J., Tracey, K., Amin, A., 2003. Differential expression of high mobility group protein in human normal and arthritic cartilage; functional genomic analysis. In: 49th Annual Meeting of the Orthopaedic Research Society, Paper 18.
7. Bertone A.L., Palmer J.L., and Jones J. Synovial fluid cytokines and eicosanoids as markers of joint disease in horses. Veterinary Surgery 30 (2001) 528-538
8. Brenn D., Richter F., and Schaible H.-G. Sensitization of unmyelinated sensory fibres of the joint nerve to mechanical stimuli by interleukin-6 in the rat: an inflammatory mechanism of joint pain. Arthritis and Rheumatism 56 (2007) 351-359
9. David F., Farley J., Huang H., Lavoie J.-P., and Laverty S. Cytokine and chemokine gene expression of IL-1β stimulated equine articular chondrocytes. Veterinary Surgery 36 (2007) 221-227
10. Field M., Chu C., Feldmann M., and Maini R.N. Interleukin-6 localisation in the synovial membrane in rheumatoid arthritis. Rheumatology International 11 (1991) 45-50
11. Flannery C.R., Little C.B., Hughes C.E., Curtis C.L., Caterson B., and Jones S.A. IL-6 and its soluble receptor augment aggrecanase-mediated proteoglycan catabolism in articular cartilage. Matrix Biology 19 (2000) 549-553
12. Goldring M.B. The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Connective Tissue Research 40 (1999) 1-11
13. Hardy J., Bertone A.L., Weisbrode S.E., Muir W.W., O'Dorisio T.M., and Masty J. Cell trafficking, mediator release, and articular metabolism in acute inflammation of innervated or denervated isolated equine joints. American Journal of Veterinary Research 59 (1998) 88-100
14. 2 values in horses. American Journal of Veterinary Research 54 (1993) 379-386
15. Hawkins D.L., Cargile J.L., MacKay R.J., Broome T.A., and Skelley L.A. Effect of tumor necrosis factor antibody on synovial fluid cytokine activities in equine antebrachiocarpal joints injected with endotoxin. American Journal of Veterinary Research 56 (1995) 1292-1299
16. Hori O., Jerold B., Slattery T., Cao R., Zhang J., Chen J.X., Nagashima M., Lundh E.R., Vijay S., Nitecki D., Morser J., Stern D., and Schmidt A.M. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin: mediation of neurite outgrowth and co-expression of RAGE and amphoterin in the developing nervous system. The Journal of Biological Chemistry 43 (1995) 25752-25761
17. Jikko A., Wakisaka T., Iwamoto M., Hiranuma H., Kato Y., Maeda T., Fujishita M., and Fuchihata H. Effects of interleukin-6 on proliferation and proteoglycan metabolism in articular chondrocyte cultures. Cell Biology International 22 (1998) 615-621
18. Jones S.A. Directing transition from innate to acquired immunity: defining a role for IL-6. The Journal of Immunology 175 (2005) 3463-3468
19. Kokkola R., Sundberg E., Ulfgren A.-K., Palmblad K., Li J., Wang H., Ulloa L., Yang H., Yan X.-J., Furie R., Chiorazzi N., Tracey K.J., Andersson U., and Erlandsson Harris H. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis and Rheumatism 46 (2002) 2598-2603
20. Krenn V., Morawietz L., Burmester G.-R., Kinne R.W., Mueller-Ladner U., Muller B., and Haupl T. Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology 49 (2006) 358-364
21. Ley C., Ekman S., Elmén A., Nilsson G., and Eloranta M.-L. Interleukin-6 and tumour necrosis factor in synovial fluid from horses with carpal joint pathology. Journal of Veterinary Medicine A Physiology, Pathology, Clinical Medicine 54 (2007) 346-351
22. Loeser R.F., Yammani R.R., Carlson C.S., Chen H., Cole A., Im H.-J., Bursch L.S., and Yan S.D. Articular chondrocytes express the receptor for advanced glycation end products: potential role in osteoarthritis. Arthritis and Rheumatism 52 (2005) 2376-2385
23. McIlwraith C.W. General pathobiology of the joint and response to injury. In: McIlwraith C.W., and Trotter G.W. (Eds). Joint Disease in the Horse. first ed. (1996), W.B. Saunders Company, Philadelphia 40-70
24. McIlwraith C.W., and Bramlage L.R. Surgical treatment of joint injury. In: McIlwraith C.W., and Trotter G.W. (Eds). Joint Disease in the Horse. first ed. (1996), W.B. Saunders Company, Philadelphia 292-317
25. Middleton J., Manthey A., and Tyler J. Insulin-like growth factor (IGF) receptor, IGF-I, Interleukin-1β (IL-1β) and IL-6 mRNA expression in osteoarthritic and normal human cartilage. The Journal of Histochemistry and Cytochemistry 44 (1996) 133-141
26. Mohtai M., Gupta M.K., Donlon B., Ellison B., Cooke J., Gibbons G., Schurman D.J., and Lane Smith R. Expression of interleukin-6 in osteoarthritic chondrocytes and effects of fluid-induced shear on this expression in normal human chondrocytes in vitro. Journal of Orthopaedic Research 14 (1996) 67-73
27. Moos V., Fickert S., Müller B., Weber U., and Sieper J. Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage. The Journal of Rheumatology 26 (1999) 870-879
28. Oegema Jr. T.R., Carpenter R.J., Hofmeister F., and Thompson Jr. R.C. The interaction of the zone of calcified cartilage and subchondral bone in osteoarthritis. Microscopy Research and Technique 37 (1997) 324-332
29. Palmblad K., Sundberg E., Diez M., Söderling R., Aveberger A.-C., Andersson U., and Erlandsson Harris H. Morphological characterization of intra-articular HMGB1 expression during the course of collagen-induced arthritis. Arthritis Research and Therapy 9 (2007) R35
30. Pool R.R. Pathologic manifestations of joint disease in the athletic horse. In: McIlwraith C.W., and Trotter G.W. (Eds). Joint Disease in the Horse. first ed. (1996), W.B. Saunders Company, Philadelphia 87-104
31. Pool R.R., and Meagher D.M. Pathologic findings and pathogenesis of racetrack injuries. In: Turner A.S., and Goodman N.L. (Eds). The Veterinary Clinics of North America: Equine practice vol.6 (1990), W.B. Saunders Company, Philadelphia 1-30
32. Pullerits R., Jonsson I.-M., Verdrengh M., Bokarewa M., Andersson U., Erlandsson-Harris H., and Tarkowski A. High mobility group box chromosomal protein 1, a DNA binding cytokine, induces arthritis. Arthritis and Rheumatism 48 (2003) 1693-1700
33. Shingu M., Nagai Y., Isayama T., Naono T., Nobunaga M., and Nagai Y. The effects of cytokines on metalloproteinase inhibitors (TIMP) and collagenase production by human chondrocytes and TIMP production by synovial cells and endothelial cells. Clinical and Experimental Immunology 94 (1993) 145-149
34. Shingu M., Miyauchi S., Nagai Y., Yasutake C., and Horie K. The role of IL-4 and IL-6 in IL-1-dependent cartilage matrix degradation. British Journal of Rheumatology 34 (1995) 101-106
35. Simmons E.J., Bertone A.L., Hardy J., and Weisbrode S.E. Nitric oxide synthase activity in healthy and interleukin1β-exposed equine synovial membrane. American Journal of Veterinary Research 60 (1999) 714-716
36. Smith M.D., Triantafillou S., Parker A., Youssef P.P., and Coleman M. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. The Journal of Rheumatology 24 (1997) 365-371
37. Taniguchi N., Kawahara K., Yone K., Hashiguchi T., Yamakuchi M., Goto M., Inoue K., Yamada S., Ijiri K., Matsunaga S., Nakajima T., Komiya S., and Maruyama I. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis and Rheumatism 48 (2003) 971-981
38. Taniguchi N., Yoshida K., Ito T., Tsuda M., Mishima Y., Furumatsu T., Ronfani L., Abeyama K., Kawahara K., Komiya S., Maruyama I., Lotz M., Bianchi M.E., and Asahara H. Stage-specific secretion of HMGB1 in cartilage regulates endochondral ossification. Molecular and Cellular Biology 27 (2007) 5650-5663
39. Trumble T.N., Trotter G.W., Thom Oxford J.R., McIlwraith C.W., Cammarata S., Goodnight J.L., Billinghurst R.C., and Frisbie D.D. Synovial fluid concentrations and matrix metalloproteinase and cytokine expression in naturally occurring joint disease in horses. American Journal of Veterinary Research 62 (2001) 1467-1477
40. Von Rechenberg B., Leutenegger C., Zlinsky K., McIlwraith C.W., Akens M.K., and Auer J.A. Upregulation of mRNA of interleukin-1 and -6 in subchondral cystic lesions of four horses. Equine Veterinary Journal 33 (2001) 143-149
41. Weaver R.E., Sharif M., Livingston L.A., Andrews K.L., and Fuller C.J. Microscopic change in macroscopically normal equine cartilage from osteoarthritic joints. Connective Tissue Research 47 (2006) 92-101
42. Yan S.F., Tritto I., Pinsky D., Liao H., Huang J., Fuller G., Brett J., May L., and Stern D. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells: central role of the binding site for nuclear factor-IL-6. The Journal of Biological Chemistry 270 (1995) 11463-11471
43. Yang H., Wang H., Czura C.J., and Tracey K.J. The cytokine activity of HMGB1. Journal of Leukocyte Biology 78 (2005) 1-8